Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for BIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 1984. Start Trial.
Date Value
December 31, 2025 532.20M
December 31, 2024 454.60M
December 31, 2023 374.94M
December 31, 2022 1.436B
December 31, 2021 -415.44M
December 31, 2020 575.33M
December 31, 2019 457.90M
December 31, 2018 285.49M
December 31, 2017 104.14M
December 31, 2016 267.83M
December 31, 2015 186.21M
December 31, 2014 273.31M
December 31, 2013 175.48M
December 31, 2012 278.90M
December 31, 2011 259.82M
December 31, 2010 225.91M
December 31, 2009 325.07M
December 31, 2008 191.37M
December 31, 2007 191.58M
December 31, 2006 118.20M
December 31, 2005 108.28M
Date Value
December 31, 2004 123.09M
December 31, 2003 127.64M
December 31, 2002 104.80M
December 31, 2001 99.50M
December 31, 2000 24.25M
December 31, 1999 44.98M
December 31, 1998 27.34M
December 31, 1997 21.11M
December 31, 1996 33.15M
December 31, 1995 38.23M
December 31, 1994 48.27M
December 31, 1993 22.53M
December 31, 1992 3.965M
December 31, 1991 4.136M
December 31, 1990 12.08M
December 31, 1989
December 31, 1988 8.645M
December 31, 1987 -6.062M
December 31, 1986 6.065M
December 31, 1985 3.092M
December 31, 1984 -2.523M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Thermo Fisher Scientific, Inc. 7.818B
Agilent Technologies, Inc. 1.559B
Danaher Corp. 6.416B
Illumina, Inc. 1.079B
Revvity, Inc. 580.46M